Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1998
11/03/1998US5830901 Tetrahydropyridinylmethyl derivatives of pyrrolo 2,3-B!pyridine
11/03/1998US5830899 Fungicides
11/03/1998US5830898 Enantiomerically pure β-di-dioxolane-nucleosides with selective anti-hepatitis B virus activity
11/03/1998US5830896 Psychological disorders; antiepilepic agents; alzheimer'sand parkinson?s disease
11/03/1998US5830895 Methods for the determination and adjustment of prolactin daily rhythms
11/03/1998US5830894 Methods for preventing and treating pestivirus infection and associated diseases
11/03/1998US5830893 Treatment of equine protozoan myeloencephalitis using triazinediones
11/03/1998US5830892 Piperidine and morphonline derivatives and their use as therapeutic agents
11/03/1998US5830889 Antibiotic in oral dosage forms
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830886 Steroid sulphatase inhibitors
11/03/1998US5830883 Methods of creating a unique chitosan and employing the same to form complexes with drugs, delivery of the same within a patient and a related dosage form
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830877 Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
11/03/1998US5830875 24-and 25-substituted avermectin and milbemycin derivatives
11/03/1998US5830874 Compositions and methods for the treatment of arterial chlamydial granuloma
11/03/1998US5830872 Esters of D-mannose or of xylitol and their use as medicaments
11/03/1998US5830870 Prevent loss of muscle mass
11/03/1998US5830854 Method of treating cystic fibrosis using a tachykinin receptor antagonist
11/03/1998US5830850 Methods for the treatment of bone resorption disorders, including osteoporosis
11/03/1998US5830758 Binding to lymphocytes
11/03/1998US5830757 Stimulation of Meiosis
11/03/1998US5830717 Process for production of tricyclo compounds with streptomyces
11/03/1998US5830710 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
11/03/1998US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998US5830686 Gene expression
11/03/1998US5830640 Analyzing for uteroglobin protein in cells
11/03/1998US5830508 Composition for treating dry eye
11/03/1998US5830505 Active ingredient patch
11/03/1998US5830503 Enteric coated diltiazem once-a-day formulation
11/03/1998US5830500 Low dose fluoxetine tablet
11/03/1998US5830498 Liposomal-polyene preliposomal powder and method for its preparation
11/03/1998US5830492 Matrix containing a hormone encapsulated with polymer
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998US5830455 Method of treatment using a therapeutic combination of α interferon and free radical scavengers
11/03/1998US5830436 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
11/03/1998US5829449 Smoking products containing antioxidants
11/03/1998CA2181929C Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker
11/03/1998CA2131789C Biologically active tropane derivatives
11/03/1998CA1340113C Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
11/03/1998CA1340111C Vectors and compounds for expression of zymogen forms of human protein c
10/1998
10/30/1998CA2236254A1 Process for preparing benzo¬b|thiophenes
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048055A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998WO1998048027A2 Materials and methods for treatment of retinal diseases
10/29/1998WO1998048009A2 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998WO1998047969A1 Alkyl, alkenyl and alkynyl chrysamine g derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
10/29/1998WO1998047915A1 Neoglycoproteins
10/29/1998WO1998047911A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998WO1998047906A1 Phosphonic acid derivatives
10/29/1998WO1998047903A1 Crf antagonistic thiophenopyridines
10/29/1998WO1998047902A1 9,10-diazatricyclo[4.2.1.12,5]decane and 9,10-diazatricyclo[3.3.1.12,6]decane derivatives having analgesic activity
10/29/1998WO1998047900A1 Heterocyclic compounds and their preparation and use
10/29/1998WO1998047898A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998WO1998047895A1 2-OXO-1-AZETIDINE SULFONIC ACID DERIVATIVES AS POTENT β-LACTAMASE INHIBITORS
10/29/1998WO1998047892A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998WO1998047890A1 Substituted benzopyran derivatives for the treatment of inflammation
10/29/1998WO1998047888A1 Kodaistatins a, b, c and d, a process for their production and their use
10/29/1998WO1998047885A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
10/29/1998WO1998047880A1 Isoxazole derivatives
10/29/1998WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998WO1998047876A1 Heterocyclic derivatives and their use as antithrombotic agents
10/29/1998WO1998047875A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
10/29/1998WO1998047874A1 Crf antagonistic quino- and quinazolines
10/29/1998WO1998047871A1 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
10/29/1998WO1998047869A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/29/1998WO1998047866A2 Arylsecocholadiene derivatives
10/29/1998WO1998047861A1 Retinoid-like compounds
10/29/1998WO1998047857A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate
10/29/1998WO1998047854A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998WO1998047537A1 Polymer-platinum compounds
10/29/1998WO1998047536A1 Controlled release of ophthalmic compositions
10/29/1998WO1998047534A1 Stabilized medicaments containing cysteinyl derivatives
10/29/1998WO1998047519A1 Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength in athletes
10/29/1998WO1998047518A1 Use of cholesterol-lowering agents to influence signal transduction processes in the cell membrane and in the prophylaxis or treatment of prion-associated diseases or alzheimer's disease
10/29/1998WO1998047517A1 Stabilized tibolone compositions
10/29/1998WO1998047515A1 THE USE OF α-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES
10/29/1998WO1998047514A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity
10/29/1998WO1998047513A1 Use of nk-1 receptor antagonists for treating eating disorders
10/29/1998WO1998047512A1 1,2,4-benzotriazine oxides formulations
10/29/1998WO1998047511A1 Use of mizolastine for preparing a medicine for treating inflammation
10/29/1998WO1998047510A1 Eye drops
10/29/1998WO1998047509A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998WO1998047508A1 Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
10/29/1998WO1998047507A1 Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
10/29/1998WO1998047506A1 Gastric-retained pharmaceutical composition
10/29/1998WO1998047505A1 Neuropeptide y receptor antagonist
10/29/1998WO1998047504A1 Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
10/29/1998WO1998047503A1 Ibuprofen suspension preparations
10/29/1998WO1998047502A1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-λB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION
10/29/1998WO1998047501A1 Pharmaceutical preparation containing nimesulide for oral administration
10/29/1998WO1998047500A1 Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
10/29/1998WO1998047499A1 Flutamide preparations and method for manufacturing the same
10/29/1998WO1998047498A1 Neuroprotective compounds and uses thereof
10/29/1998WO1998047495A1 New composition
10/29/1998WO1998047494A2 Novel use of matrix metalloproteinase inhibitors
10/29/1998WO1998047493A1 Taste masked pharmaceutical compositions
1 ... 6587 6588 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 ... 7860